Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Live and let die - Protein prevents immune cell suicide

31.05.2013
A protein called c-FLIP-R is critical to immune cell survival: If this molecule is missing, the cells kill themselves – and are thus no longer able to perform their job fighting off invaders.

Now, scientists at the Helmholtz Centre for Infection Research (HZI) Braunschweig and at the Otto von Guericke University (OvGU) Magdeburg have published their findings in the renowned European Journal of Immunology.


Liver cells under the microscope. Apoptotic cells are stained in brown, cell nuclei are blue.
HZI / Schmitz

Apoptosis, programmed cell death, is a kind of cellular suicide program. If something triggers it, the cells perish in a controlled manner. A certain type of white blood cell called a lymphocyte commits suicide by apoptosis, which is one way for the body to effectively shut down an immune response once a pathogen has been successfully fought off. To make sure this doesn’t happen until after the job is done, apoptosis is a tightly regulated process. If this regulation is lost, potential consequences include autoimmune diseases, neurodegenerative diseases, even different forms of cancer.

The protein c-FLIP figures prominently into how the body regulates this process. The protein exists as three different versions, or isoforms. While the roles of c-FLIP-L and c-FLIP-S isoforms are well established, until now relatively little has been known about the role of the c-FLIP-R isoform. Which is why Prof. Ingo Schmitz and the Braunschweig team of researchers decided to take a closer look at this particular isoform. What they found is that it confers protection on immune cells against the apoptosis program. “If c-FLIP-R is activated, lymphocytes are apoptosis-resistant,” says the head of the HZI’s Systems-oriented Immunology and Inflammation Research work group, who also teaches at the OvGU. “Apoptosis can take place only in the protein’s absence.”

Traditionally, insights like these are based on research on mice and have yet to be confirmed in humans. In this case, however, the exact opposite holds true: Schmitz and his team initially made their observations on human blood cells. Next, to test these findings at the organismal level, the researchers examined a certain strain of mice that were making c-FLIP in all of their blood cells. The result: “Although the animals’ immune system was unchanged, c-FLIP prevents their white blood cells from undergoing apoptosis,” explains immunologist Prof. Dunja Bruder, who also teaches in Magdeburg.
As a result, the mice are less susceptible to Listeria infections. The bacterium, which also infects humans, is transmitted via contaminated foods. “The mice have a lower bacterial count and a lesser extent of organ damage than is normally the case with Listeria,” says Bruder. Consistently high levels of c-FLIP, however, would permanently disable apoptosis in activated lymphocytes and could trigger different autoimmune diseases. The scientists are hoping to conduct further, more in-depth research on this particular topic.

Still, for Ingo Schmitz, there is one obvious potential medical benefit to the discovery: “If we were able to simply turn on c-FLIP-R, this would help strengthen the immune system.” Helping the body heal itself if you will. A highly promising approach that could prove important to pretty much every single disease. Schmitz is already working on mapping out the search for candidate active substances.

Original publication:
Tanja Telieps, Frida Ewald, Marcus Gereke, Michaela Annemann, Yvonne Rauter, Marc Schuster, Nana Ueffing, Dorthe von Smolinski, Achim D. Gruber, Dunja Bruder, Ingo Schmitz
c-FLIP-R modulates cell death induction upon T-cell activation and infection
European Journal of Immunology, 2013, DOI: 10.1002/eji.201242819

The Systems-oriented Immunology and Inflammation Research work group studies the molecular processes that sensitize immune cells to the body’s own tissues. The cellular suicide program apop-tosis figures prominently into this research.

The HZI’s Immune regulation work group studies the balance of the immune system in extreme situations. This includes, among others, simultaneous infection with different kinds of pathogens and the misguided attack of the body’s own parts.

The Helmholtz Center for Infection Research:
Scientists at the Helmholtz Center for Infection Research (HZI) are engaged in the study of different mechanisms of infection and of the body’s response to infection. Helping to improve the scientific community’s understanding of a given bacterium’s or virus’ pathogenicity is key to developing effective new treatments and vaccines.
http://www.helmholtz-hzi.de

The Otto von Guericke University Magdeburg:
One of the Otto von Guericke University Magdeburg Medical Faculty’s research emphases is “Immunology including the molecular medicine of inflammation” with the goal of developing new therapeutic approaches and their delivery to the patient.

http://www.uni-magdeburg.de

Weitere Informationen:
http://www.helmholtz-hzi.de/en/news_events/news/view/article/complete/live_and_let_die/

- This press release at helmholtz-hzi.de

http://dx.doi.org/10.1002/eji.201242819
- Link to the original publication

Dr. Jan Grabowski | Helmholtz-Zentrum
Further information:
http://www.helmholtz-hzi.de
http://www.uni-magdeburg.de

More articles from Life Sciences:

nachricht What happens in the cell nucleus after fertilization
06.12.2016 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Simple processing technique could cut cost of organic PV and wearable electronics

06.12.2016 | Materials Sciences

3-D printed kidney phantoms aid nuclear medicine dosing calibration

06.12.2016 | Medical Engineering

Robot on demand: Mobile machining of aircraft components with high precision

06.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>